Developmental Study of Fragile X Syndrome Using Human Embryonic Stem Cells Derived from Preimplantation Genetically Diagnosed Embryos

Cell Stem Cell

Volumn 1, Issue 5, 2007, Pages 568-577

  Eiges, Rachel ^a   Urbach, Achia ^a   Malcov, Mira ^b   Frumkin, Tsvia ^b   Schwartz, Tamar ^b   Amit, Ami ^b   Yaron, Yuval ^c   Eden, Amir ^a   Yanuka, Ofra ^a   Benvenisty, Nissim ^a   Ben Yosef, Dalit ^b  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b LIS MATERNITY HOSPITAL   (Israel)

^c TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

HUMDISEASE; STEMCELL

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN; HISTONE;

5' UNTRANSLATED REGION; ARTICLE; CELL DIFFERENTIATION; CELL LINE; CONTROLLED STUDY; DNA METHYLATION; EMBRYO; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; EPIGENETICS; FRAGILE X SYNDROME; GENE INACTIVATION; GENE MUTATION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; PATHOGENESIS; PREIMPLANTATION EMBRYO; PRIORITY JOURNAL; PROTEIN MODIFICATION; TRINUCLEOTIDE REPEAT;

ANIMALS; BLASTOCYST; CELL DIFFERENTIATION; CELL LINE; DNA METHYLATION; EMBRYONIC STEM CELLS; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; GENE SILENCING; HISTONES; HUMANS; MICE; MICE, SCID; MUTATION; PREIMPLANTATION DIAGNOSIS; TERATOMA; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 35848937244     PISSN: 19345909     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.stem.2007.09.001     Document Type: Article

References (41)

1. Bontekoe C.J., de Graaff E., Nieuwenhuizen I.M., Willemsen R., and Oostra B.A. FMR1 premutation allele (CGG)81 is stable in mice. Eur. J. Hum. Genet. 5 (1997) 293-298
2. Bontekoe C.J., Bakker C.E., Nieuwenhuizen I.M., van der Linde H., Lans H., de Lange D., Hirst M.C., and Oostra B.A. Instability of a (CGG)98 repeat in the Fmr1 promoter. Hum. Mol. Genet. 10 (2001) 1693-1699
3. Brouwer J.R., Mientjes E.J., Bakker C.E., Nieuwenhuizen I.M., Severijnen L.A., Van der Linde H.C., Nelson D.L., Oostra B.A., and Willemsen R. Elevated Fmr1 mRNA levels and reduced protein expression in a mouse model with an unmethylated Fragile X full mutation. Exp. Cell Res. 313 (2007) 244-253
4. Burman R.W., Popovich B.W., Jacky P.B., and Turker M.S. Fully expanded FMR1 CGG repeats exhibit a length- and differentiation-dependent instability in cell hybrids that is independent of DNA methylation. Hum. Mol. Genet. 8 (1999) 2293-2302
5. Coffee B., Zhang F., Warren S.T., and Reines D. Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells. Nat. Genet. 22 (1999) 98-101
6. Coffee B., Zhang F., Ceman S., Warren S.T., and Reines D. Histone modifications depict an aberrantly heterochromatinized FMR1 gene in fragile x syndrome. Am. J. Hum. Genet. 71 (2002) 923-932
7. Crawford D.C., Acuna J.M., and Sherman S.L. FMR1 and the fragile X syndrome: human genome epidemiology review. Genet. Med. 3 (2001) 359-371
8. Darr H., Mayshar Y., and Benvenisty N. Overexpression of NANOG in human ES cells enables feeder-free growth while inducing primitive ectoderm features. Development 133 (2006) 1193-1201
9. Dvash T., and Benvenisty N. Human embryonic stem cells as a model for early human development. Best Pract. Res. Clin. Obstet. Gynaecol. 18 (2004) 929-940
10. Dvash T., Mayshar Y., Darr H., McElhaney M., Barker D., Yanuka O., Kotkow K.J., Rubin L.L., Benvenisty N., and Eiges R. Temporal gene expression during differentiation of human embryonic stem cells and embryoid bodies. Hum. Reprod. 19 (2004) 2875-2883
11. Dvash T., Ben-Yosef D., and Eiges R. Human embryonic stem cells as a powerful tool for studying human embryogenesis. Pediatr. Res. 60 (2006) 111-117
12. Eberhart D.E., and Warren S.T. Nuclease sensitivity of permeabilized cells confirms altered chromatin formation at the fragile X locus. Somat. Cell Mol. Genet. 22 (1996) 435-441
13. Eiges R., and Benvenisty N. A molecular view on pluripotent stem cells. FEBS Lett. 529 (2002) 135-141
14. Eiges R., Schuldiner M., Drukker M., Yanuka O., Itskovitz-Eldor J., and Benvenisty N. Establishment of human embryonic stem cell-transfected clones carrying a marker for undifferentiated cells. Curr. Biol. 11 (2001) 514-518
15. Feldman N., Gerson A., Fang J., Li E., Zhang Y., Shinkai Y., Cedar H., and Bergman Y. G9a-mediated irreversible epigenetic inactivation of Oct-3/4 during early embryogenesis. Nat. Cell Biol. 8 (2006) 188-194
16. Feng Y., Zhang F., Lokey L.K., Chastain J.L., Lakkis L., Eberhart D., and Warren S.T. Translational suppression by trinucleotide repeat expansion at FMR1. Science 268 (1995) 731-734
17. Grewal S.I., and Jia S. Heterochromatin revisited. Nat. Rev. Genet. 8 (2007) 35-46
18. Itskovitz-Eldor J., Schuldiner M., Karsenti D., Eden A., Yanuka O., Amit M., Soreq H., and Benvenisty N. Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol. Med. 6 (2000) 88-95
19. Lavedan C.N., Garrett L., and Nussbaum R.L. Trinucleotide repeats (CGG)22TGG(CGG)43TGG(CGG)21 from the fragile X gene remain stable in transgenic mice. Hum. Genet. 100 (1997) 407-414
20. Lavedan C., Grabczyk E., Usdin K., and Nussbaum R.L. Long uninterrupted CGG repeats within the first exon of the human FMR1 gene are not intrinsically unstable in transgenic mice. Genomics 50 (1998) 229-240
21. Lock L.F., Takagi N., and Martin G.R. Methylation of the Hprt gene on the inactive X occurs after chromosome inactivation. Cell 48 (1987) 39-46
22. Malcov M., Naiman T., Ben Yosef D., Carmon A., Mey-Raz N., Amit A., Vagman I., and Yaron Y. Preimplantation genetic diagnosis (PGD) for fragile X syndrome using multiplex nested PCR of the FMR1 CGG-repeat region, the SRY gender marker and flanking polymorphic markers. Reprod. Biomed. Online 14 (2007) 515-521
23. Nolin S.L., Lewis III F.A., Ye L.L., Houck Jr. G.E., Glicksman A.E., Limprasert P., Li S.Y., Zhong N., Ashley A.E., Feingold E., et al. Familial transmission of the FMR1 CGG repeat. Am. J. Hum. Genet. 59 (1996) 1252-1261
24. Oberle I., Rousseau F., Heitz D., Kretz C., Devys D., Hanauer A., Boue J., Bertheas M.F., and Mandel J.L. Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science 252 (1991) 1097-1102
25. O'Donnell W.T., and Warren S.T. A decade of molecular studies of fragile X syndrome. Annu. Rev. Neurosci. 25 (2002) 315-338
26. Panagopoulos I., Lassen C., Kristoffersson U., and Aman P. A methylation PCR approach for detection of fragile X syndrome. Hum. Mutat. 14 (1999) 71-79
27. Peier A.M., and Nelson D.L. Instability of a premutation-sized CGG repeat in FMR1 YAC transgenic mice. Genomics 80 (2002) 423-432
28. Pickering S.J., Minger S.L., Patel M., Taylor H., Black C., Burns C.J., Ekonomou A., and Braude P.R. Generation of a human embryonic stem cell line encoding the cystic fibrosis mutation deltaF508, using preimplantation genetic diagnosis. Reprod. Biomed. Online 10 (2005) 390-397
29. Pietrobono R., Pomponi M.G., Tabolacci E., Oostra B., Chiurazzi P., and Neri G. Quantitative analysis of DNA demethylation and transcriptional reactivation of the FMR1 gene in fragile X cells treated with 5-azadeoxycytidine. Nucleic Acids Res. 30 (2002) 3278-3285
30. Pietrobono R., Tabolacci E., Zalfa F., Zito I., Terracciano A., Moscato U., Bagni C., Oostra B., Chiurazzi P., and Neri G. Molecular dissection of the events leading to inactivation of the FMR1 gene. Hum. Mol. Genet. 14 (2005) 267-277
31. Schuldiner M., Yanuka O., Itskovitz-Eldor J., Melton D.A., and Benvenisty N. Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells. Proc. Natl. Acad. Sci. USA 97 (2000) 11307-11312
32. Smeets H.J., Smits A.P., Verheij C.E., Theelen J.P., Willemsen R., van de Burgt I., Hoogeveen A.T., Oosterwijk J.C., and Oostra B.A. Normal phenotype in two brothers with a full FMR1 mutation. Hum. Mol. Genet. 4 (1995) 2103-2108
33. Sutcliffe J.S., Nelson D.L., Zhang F., Pieretti M., Caskey C.T., Saxe D., and Warren S.T. DNA methylation represses FMR-1 transcription in fragile X syndrome. Hum. Mol. Genet. 1 (1992) 397-400
34. Tabolacci E., Pietrobono R., Moscato U., Oostra B.A., Chiurazzi P., and Neri G. Differential epigenetic modifications in the FMR1 gene of the fragile X syndrome after reactivating pharmacological treatments. Eur. J. Hum. Genet. 13 (2005) 641-648
35. The Dutch-Belgian Fragile X Consortium. Fmr1 knockout mice: a model to study fragile X mental retardation. Cell 78 (1994) 23-33
36. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., and Jones J.M. Embryonic stem cell lines derived from human blastocysts. Science 282 (1998) 1145-1147
37. Urbach A., Schuldiner M., and Benvenisty N. Modeling for Lesch-Nyhan disease by gene targeting in human embryonic stem cells. Stem Cells 22 (2004) 635-641
38. Verkerk A.J., Pieretti M., Sutcliffe J.S., Fu Y.H., Kuhl D.P., Pizzuti A., Reiner O., Richards S., Victoria M.F., Zhang F.P., et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65 (1991) 905-914
39. Verlinsky Y., Strelchenko N., Kukharenko V., Rechitsky S., Verlinsky O., Galat V., and Kuliev A. Human embryonic stem cell lines with genetic disorders. Reprod. Biomed. Online 10 (2005) 105-110
40. Willemsen R., Bontekoe C.J., Severijnen L.A., and Oostra B.A. Timing of the absence of FMR1 expression in full mutation chorionic villi. Hum. Genet. 110 (2002) 601-605
41. Wohrle D., Salat U., Hameister H., Vogel W., and Steinbach P. Demethylation, reactivation, and destabilization of human fragile X full-mutation alleles in mouse embryocarcinoma cells. Am. J. Hum. Genet. 69 (2001) 504-515